EMERYVILLE, Calif., April 27,
2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL),
the functional cell biology company, today announced that the
Company will be reporting financial results for the first quarter
2023 after market on Thursday, May 11,
2023. Company management will be webcasting a corresponding
conference call beginning at 1:30 p.m.
Pacific Time / 4:30 p.m. Eastern
Time.
Live audio of the webcast will be available on the "Investors"
section of the Company's website at www.phenomex.com. The webcast
will be archived and available for replay after the
event.
About PhenomeX Inc.
PhenomeX is empowering scientists to leverage the full potential
of each cell and drive the next era of functional cell biology that
will advance human health. We enable scientists to reveal the most
complete insights on cell function and obtain a full view of the
behavior of each cell. Our unique suite of proven high-throughput
tools and services offer unparalleled resolution and speed,
accelerating the insights that are key to advancing discoveries
that can profoundly improve the prevention and treatment of
disease. Our award-winning platforms are used by researchers
across the globe, including those at the top 15 global
pharmaceutical companies and approximately 85% of leading U.S.
comprehensive cancer centers.
Forward-Looking Statements
To the extent that statements contained in this press release
are not descriptions of historical facts regarding PhenomeX or its
products, they are forward-looking statements reflecting the
current beliefs and expectations of management. Such
forward-looking statements involve substantial known and unknown
risks and uncertainties that relate to future events, and actual
results and product performance could differ significantly from
those expressed or implied by the forward-looking statements.
PhenomeX undertakes no obligation to update or revise any
forward-looking statements. For a further description of the risks
and uncertainties relating to the Company's growth and continual
evolution see the statements in the "Risk Factors" sections, and
elsewhere, in our filings with the U.S. Securities and Exchange
Commission.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/phenomex-to-report-first-quarter-2023-financial-results-on-may-11-2023-301810259.html
SOURCE PhenomeX